DOCSLIB.ORG

Molecular Cloning and Characterization of Cystatin, a Cysteine Protease Inhibitor, from Bufo Melanostictus

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Molecular Cloning and Characterization of Cystatin, a Cysteine Protease Inhibitor, from Bufo Melanostictus Biosci. Biotechnol. Biochem., 77 (10), 2077–2081, 2013 Molecular Cloning and Characterization of Cystatin, a Cysteine Protease Inhibitor, from Bufo melanostictus y Wa LIU,1 Senlin JI,1 A-Mei ZHANG,2 Qinqin HAN,1 Yue FENG,2 and Yuzhu SONG1; 1Engineering Research Center for Molecular Diagnosis, Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan 650500, China 2Laboratory of Molecular Virology, Faculty of Life Sciences and Technology, Kunming University of Science and Technology, Kunming, Yunnan 650500, China Received May 31, 2013; Accepted July 17, 2013; Online Publication, October 7, 2013 [doi:10.1271/bbb.130424] Cystatins are efficient inhibitors of papain-like cys- inhibit pathogens, such as CP1 from green kiwi fruit, teine proteinases, and they serve various important which exhibits antifungal activity against Alternaria physiological functions. In this study, a novel cystatin, radicina and Botrytis cinerea both in vitro and in vivo;2) Cystatin-X, was cloned from a cDNA library of the skin the cystatin gene in wheat, which provides resistance of Bufo melanostictus. The single nonglycosylated poly- against Karnal bunt, caused by Tilletia indica;3) and peptide chain of Cystatin-X consisted of 102 amino acid chicken cystatins, which inhibit the growth of Porphyr- residues, including seven cysteines. Evolutionary analy- omonas gingivalis.4) A small number of cystatins from sis indicated that Cystatin-X can be grouped with family amphibians have been identified by means of genome 1 cystatins. It contains cystatin-conserved motifs known and transcriptome sequencing, but their functions have to interact with the active site of cysteine proteinases. not been studied. Recombinant Cystatin-X expressed and purified from Cathepsin B has been co-expressed with cystatin A in Escherichia coli exhibited obvious inhibitory activity primary tumors and metastases, suggesting that cystatin against cathepsin B. rCystatin-X at a concentration of A suppresses metastasis via inhibition of cathepsin B.5) 8 M inhibited nearly 80% of cathepsin B activity within Cathepsin B is a lysosomal cysteine protease primarily 15 s, and about 90% of cathepsin B activity within involved in the degradation and processing of lysosomal 15 min. The Cystatin-X identified in this study can play proteins. Under certain conditions, it has been found to an important role in host immunity and in the medical be involved in additional cellular processes, including effect of B. melanostictus. cell invasion, vesicle trafficking, inflammasome forma- tion, and cell death.6) Key words: amphibian skin; cysteine proteinase inhib- The stratum corneum exuviated by the black-specta- itor; cDNA screening cled toad (Bufo melanostictus) is one of the most popular sources of chanyi, a traditional Chinese medi- Cystatins, inhibitors of papain-like cysteine proteases, cine that is used to treat hepatitis B, sores, and various are ubiquitous in plants and animals. They are catego- cancers. Certain bioactive ingredients have been isolated rized into three major families: (i) Family 1 (stefins) are from the skin of B. melanostictus, including bufadieno- unglycosylated inhibitors of about 11 kDa that lack lide sulfates and BMP1.7,8) The stratum corneum of the signal sequences and disulfide bonds. Stefin A and B skin is an important barrier of the host immune system (also known as cystatin A and B) belong to this family. against external injury. Amphibian skin contains abun- (ii) Family 2 (cystatins) have molecular masses ranging dant bioactive peptides, particularly antimicrobial pep- from 13 kDa to 14 kDa and contain signal peptide and tides and protease inhibitors, which provide efficient disulfide bonds at the carboxy terminus. Some members protection. Up to 2,000 antimicrobial peptides and 200 of this family are glycosylated, and the family is protease inhibitors have been identified in amphibian represented by cystatin C, D, S, SA, and SN. (iii) skin,9) but none have been reported for B. melanostictus. Family 3 (kininogens) have molecular masses ranging In our previous study, no antimicrobial activity was from 88 kDa to 114 kDa, are glycosylated, and have detected in the skin secretion of B. melanostictus three family 2 cystatin domains, two of which (domains (unpublished data). Considering the multiple functions 2 and 3) exhibit protease inhibitory activity.1) of cystatin, it is reasonabe to hypothesize that it serves Cystatins can efficiently inhibit endogenous and an important role in host immunity and officinal effect. extraneous cysteine proteinases, and have important Here we report the cloning, prokaryotic expression, physiological functions in the immune system, including and biological functions of cystatin obtained from steadying host-parasite interaction and defending against B. melanostictus (Cystatin-X). pathogens. They can function as the dominant biochem- ical skin barrier. Cystatin A, which is produced by Materials and Methods keratinocytes, can eliminate the enzymatic activity of parasite cysteine proteases and prevent them from cDNA library construction. Adult B. melanostictus was collected stimulating keratinocytes. Some cystatins can directly from Xishuangbanna, Yunnan Province, China. Total RNA was y To whom correspondence should be addressed. Fax: +86-871-65939528; E-mail: [email protected] 2078 W. LIU et al. extracted from the dorsal skin with TRIzol reagent (Invitrogen, pH dependency assay was done by the procedure reported earlier by Carlsbad, USA). First-strand cDNA was synthesized with a Liu et al., but with minor modifications. In brief, purified rCystatin-X SMARTerÔ polymerase chain reaction (PCR) cDNA Synthesis Kit (2 mM) was pre-incubated with assay buffers of different pH values, (Clontech, Mountain View, USA) with CDS III primer (50-ATTGAC- sodium acetate buffer (pH 3, 4, 5, and 6), sodium phosphate buffer TCGAGTCGACATCGATTTTTTTTTTTTTTTTTT-30) and SMART (pH 7 and 8), and Tris–HCl buffer (pH 9), for 5 min at 37 C. The II A oligonucleotide (50-AAGCAGTGGTATCAACGCAGAGTAC- mixture was added to the substrate, and this was incubated at 37 C for XXXXX-30). The second strand was amplified with ExTaq polymerase 30 min. Finally, the absorbance at 405 nm was measured.18) (Takara, Otsu, Japan) with 50 PCR primer II A (50-AAGCAGTGGTA- TCAACGCAGAGT-30) and 30 primer R1 (50-ATTGACTCGAGTCG- Results ACATCGA-30).10) Molecular cloning and sequence analysis Molecular cloning and sequence analysis. The synthesized cDNA Upon screening the skin cDNA library as indicated was used as template for PCR to screen the cDNAs encoding cystatin A. Two oligonucleotide primers, S1 (50-CCYGCCACYSCAGARRT- above, several clones containing inserts of about 400 ICA-30) and S2 (50-CAAGTNGTBGCHGGRDIVA-30), in the sense base pairs were identified and isolated. A cystatin direction, were designed according to the conserved sequences of homolog, Cystatin-X, was deduced from the nucleotide cystatin A from the vertebrata. Nested PCRs were performed together sequences (GenBank accession no. KF019630). The with R1 in the antisense direction. The PCR reaction was performed in open reading frames were composed of 102 amino acids a volume of 50 mL as follows: initial denaturation at 95 C for 3 min, 25 (Fig. 1). cycles of denaturation at 94 C for 30 s, annealing at 54.8 C for 30 s, Based on SignalP analysis, Cystatin-X may not extension at 72 C for 30 s, and final extension at 72 C for 5 min. The PCR products were cloned into pMD19-T Vector (Takara, Otsu, contain a signal peptide and is unlikely to be exposed Japan). DNA sequencing was performed on an Applied Biosystems to the glycosylation machinery. Glycosylation site DNA sequencer, model ABI PRISM 377. Another primer, R2 (50- prediction using NetOGlyc 3.1 and NetNGlyc 1.0 server CTAAAAATAACAGATGGGGTCT-30), was then designed according also indicated that Cystatin-X might not contain poten- to the sequenced nucleotide sequence, together with 50 PCR Primer II tial motifs to be glycosylated. 0 A, to amplify the 5 ends of the cDNA. Figure 2a compares the primary sequence for Cys- The nucleotide sequence were analyzed by BLAST and Translate Tool (http://web.expasy.org/translate/) to deduce the amino acid tatin-X with homologs from the vertebrate. Cystatin-X sequence.11) Then signal peptide and glycosylation prediction were contained the three conserved cysteine protease inhibitor performed using SignalP and NetOGlyc/NetNGlyc respectively.12,13) signature sequences critical to the biological function of Three-dimensional structure was predicted at Quark server (http: cystatins. Evolutionary analysis indicated that Cystatin- //zhanglab.ccmb.med.umich.edu/QUARK/).14) Evolutionary analyses X can be grouped among family 1 cystatins (Fig. 2b). 15) were conducted by MEGA5. In brief, multiple alignment of the The structure of Cystatin-X was predicted with the amino acid sequences were done using MUSCLE, and then the Quark Server.19) Three structural elements, G in the evolutionary history was inferred by the minimum evolution method together with the bootstrap test (10,000 replicates). N-terminal region, QVVAG at the first binding loop connecting the second and third -strands, and LP at the Expression and purification of recombinant Cystatin-X. The second binding loop between the fourth and fifth strands protein-encoding fragment of the Cystatin-X cDNA was subcloned of the -sheet, were similar to cystatin A (PDB 1G63) into pET32a (Novagen, Darmstadt, Germany), and expression of the (Fig. 3). recombinant Cystatin-X (rCystatin-X) as a His-tagged protein in transformant Escherichia coli BL21 (DE3) was induced by adding Expression and purification of rCystatin-X isopropyl -D-thiogalactopyranoside (IPTG, final concentration Cystatin-X was expressed abundantly as a soluble, 0.4 mM)at30C.16) The bacteria were lysed and treated with DNase and RNase. Soluble rCystatin-X was purified with Ni Sepharose 6 recombinant, HIS-tagged protein in E. coli BL21 (DE3) Fast Flow affinity media (GE, Freiburg, USA) and cleaved with after induction with IPTG and purification by HIS-tag enterokinase following the manufacturer’s instructions. Briefly, a affinity chromatography under non-denaturing condi- concentrated expression solution was loaded after dialysis on an tions.
Load more

Recommended publications
  • Cystatins in Immune System
    Journal of Cancer 2013, Vol. 4 45 Ivyspring International Publisher Journal of Cancer 2013; 4(1): 45-56. doi: 10.7150/jca.5044 Review Cystatins in Immune System Špela Magister1 and Janko Kos1,2 1. Jožef Stefan Institute, Department of Biotechnology, Ljubljana, Slovenia; 2. University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia. Corresponding author: Janko Kos, Ph. D., Department of Biotechnology, Jožef Stefan Institute, &Faculty of Pharmacy, University of Ljubljana, Slovenia; [email protected]; Phone+386 1 4769 604, Fax +3861 4258 031. © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. Received: 2012.10.22; Accepted: 2012.12.01; Published: 2012.12.20 Abstract Cystatins comprise a large superfamily of related proteins with diverse biological activities. They were initially characterised as inhibitors of lysosomal cysteine proteases, however, in recent years some alternative functions for cystatins have been proposed. Cystatins pos- sessing inhibitory function are members of three families, family I (stefins), family II (cystatins) and family III (kininogens). Stefin A is often linked to neoplastic changes in epithelium while another family I cystatin, stefin B is supposed to have a specific role in neuredegenerative diseases. Cystatin C, a typical type II cystatin, is expressed in a variety of human tissues and cells. On the other hand, expression of other type II cystatins is more specific. Cystatin F is an endo/lysosome targeted protease inhibitor, selectively expressed in immune cells, suggesting its role in processes related to immune response.
    [Show full text]
  • Disease in a Murine Psoriasis Model Identification of Susceptibility Loci
    The Journal of Immunology Identification of Susceptibility Loci for Skin Disease in a Murine Psoriasis Model1 Daniel Kess,2*‡ Anna-Karin B. Lindqvist,2§ Thorsten Peters,*‡ Honglin Wang,* Jan Zamek,‡ Roswitha Nischt,‡ Karl W. Broman,¶ Robert Blakytny,† Thomas Krieg,‡ Rikard Holmdahl,§ and Karin Scharffetter-Kochanek3*‡ Psoriasis is a frequently occurring inflammatory skin disease characterized by thickened erythematous skin that is covered with silvery scales. It is a complex genetic disease with both heritable and environmental factors contributing to onset and severity. The ␤ CD18 hypomorphic PL/J mouse reveals reduced expression of the common chain of 2 integrins (CD11/CD18) and spontaneously develops a skin disease that closely resembles human psoriasis. In contrast, CD18 hypomorphic C57BL/6J mice do not demon- strate this phenotype. In this study, we have performed a genome-wide scan to identify loci involved in psoriasiform dermatitis under the condition of low CD18 expression. Backcross analysis of a segregating cross between susceptible CD18 hypomorphic PL/J mice and the resistant CD18 hypomorphic C57BL/6J strain was performed. A genome-wide linkage analysis of 94 pheno- typically extreme mice of the backcross was undertaken. Thereafter, a complementary analysis of the regions of interest from the genome-wide screen was done using higher marker density and further mice. We found two loci on chromosome 10 that were significantly linked to the disease and interacted in an additive fashion in its development. In addition, a locus on chromosome 6 that promoted earlier onset of the disease was identified in the most severely affected mice. For the first time, we have identified genetic regions associated with psoriasis in a mouse model resembling human psoriasis.
    [Show full text]
  • Functional Characterization of Extracellular Protease Inhibitors of Phytophthora Infestans
    FUNCTIONAL CHARACTERIZATION OF EXTRACELLULAR PROTEASE INHIBITORS OF PHYTOPHTHORA INFESTANS DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Miaoying Tian, M.S. * * * * * The Ohio State University 2005 Dissertation Committee: Dr. Sophien Kamoun, Adviser Dr. Terrence L. Graham Approved by Dr. Saskia A. Hogenhout Dr. Margaret G. Redinbaugh Adviser Dr. Guo-Liang Wang Graduate Program in Plant Pathology ABSTRACT The oomycetes form one of several lineages within the eukaryotes that independently evolved a parasitic lifestyle and are thought to have developed unique mechanisms of pathogenicity. The devastating oomycete plant pathogen Phytophthora infestans causes late blight, a ravaging disease of potato and tomato. Little is known about processes associated with P. infestans pathogenesis, particularly the suppression of host defense responses. We used data mining of P. infestans sequence databases to identify 18 extracellular protease inhibitors belonging to two major structural classes: (i) Kazal-like serine protease inhibitors (EPI1 to EPI14) and (ii) cystatin-like cysteine protease inhibitors (EPIC1 to EPIC4). A variety of molecular, biochemical and bioinformatic approaches were employed to functionally characterize these genes and investigate their roles in pathogen virulence. The 14 EPI proteins form a diverse family and appear to have evolved by domain shuffling, gene duplication, and diversifying selection to target a diverse array of serine proteases. Recombinant EPI1 and EPI10 proteins inhibited subtilisin A among major serine proteases, and inhibited and interacted with tomato P69B subtilase, a pathogenesis-related protein belonging to PR7 class. The recombinant cystatin-like cysteine protease inhibitor EPIC2B interacted with a novel tomato papain-like extracellular cysteine protease PIP1 with an implicated role in plant defense.
    [Show full text]
  • Cystatin M/E Variant Causes Autosomal Dominant
    fgene-12-689940 July 5, 2021 Time: 19:33 # 1 ORIGINAL RESEARCH published: 12 July 2021 doi: 10.3389/fgene.2021.689940 Cystatin M/E Variant Causes Autosomal Dominant Keratosis Follicularis Spinulosa Decalvans by Edited by: Tommaso Pippucci, Dysregulating Cathepsins L and V Unità Genetica Medica, Policlinico Sant’Orsola-Malpighi, Italy Katja M. Eckl1†, Robert Gruber2†, Louise Brennan1, Andrew Marriott1, Roswitha Plank3,4, Reviewed by: Verena Moosbrugger-Martinz2, Stefan Blunder2, Anna Schossig4, Janine Altmüller5, Caterina Marconi, Holger Thiele5, Peter Nürnberg5, Johannes Zschocke4, Hans Christian Hennies3,5* and Hôpitaux Universitaires de Genève, Matthias Schmuth2* Switzerland Xuanye Cao, 1 Department of Biology, Edge Hill University, Ormskirk, United Kingdom, 2 Department of Dermatology, Medical University Baylor College of Medicine, of Innsbruck, Innsbruck, Austria, 3 Department of Biological and Geographical Sciences, University of Huddersfield, United States Huddersfield, United Kingdom, 4 Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria, 5 Cologne Center for Genomics, Faculty of Medicine and Cologne University Hospital, University of Cologne, Cologne, Germany *Correspondence: Hans Christian Hennies [email protected] Keratosis follicularis spinulosa decalvans (KFSD) is a rare cornification disorder with Matthias Schmuth [email protected] an X-linked recessive inheritance in most cases. Pathogenic variants causing X-linked †These authors have contributed KFSD have been described in MBTPS2, the gene for a membrane-bound zinc equally to this work metalloprotease that is involved in the cleavage of sterol regulatory element binding proteins important for the control of transcription. Few families have been identified with Specialty section: This article was submitted to an autosomal dominant inheritance of KFSD.
    [Show full text]
  • Expression of a Barley Cystatin Gene in Maize Enhances Resistance Against Phytophagous Mites by Altering Their Cysteine-Proteases
    Expression of a barley cystatin gene in maize enhances resistance against phytophagous mites by altering their cysteine-proteases Laura Carrillo • Manuel Martínez • Koreen Ramessar • Inés Cambra • Pedro Castañera • Félix Ortego • Isabel Díaz Abstract Phytocystatins are inhibitors of cysteine-prote­ reproductive performance. Besides, a significant reduction ases from plants putatively involved in plant defence based of cathepsin L-like and/or cathepsin B-like activities was on their capability of inhibit heterologous enzymes. We observed when the spider mite fed on maize plants have previously characterised the whole cystatin gene expressing HvCPI-6 cystatin. These findings reveal the family members from barley (HvCPI-1 to HvCPI-13). The potential of barley cystatins as acaricide proteins to protect aim of this study was to assess the effects of barley cyst- plants against two important mite pests. atins on two phytophagous spider mites, Tetranychus urticae and Brevipalpus chilensis. The determination of Keywords Cysteine protease • Phytocystatin • Spider proteolytic activity profile in both mite species showed the mite • Transgenic maize • Tetranychus urticae • presence of the cysteine-proteases, putative targets of Brevipalpus chilensis cystatins, among other enzymatic activities. All barley cystatins, except HvCPI-1 and HvCPI-7, inhibited in vitro mite cathepsin L- and/or cathepsin B-like activities, Introduction HvCPI-6 being the strongest inhibitor for both mite species. Transgenic maize plants expressing HvCPI-6 Crop losses due to herbivorous pest, mainly insects and protein were generated and the functional integrity of the mites, are estimated to be about 8-15% of the total yield cystatin transgene was confirmed by in vitro inhibitory for major crops worldwide, despite pesticide use (Oerke effect observed against T urticae and B.
    [Show full text]
  • Association Analysis of the Skin Barrier Gene Cystatin a at the PSORS5 Locus in Psoriatic Patients: Evidence for Interaction Between PSORS1 and PSORS5
    European Journal of Human Genetics (2008) 16, 1002–1009 & 2008 Nature Publishing Group All rights reserved 1018-4813/08 $30.00 www.nature.com/ejhg ARTICLE Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5 Yiannis Vasilopoulos1,3,4, Kevin Walters1,4, Michael J Cork1, Gordon W Duff1, Gurdeep S Sagoo2 and Rachid Tazi-Ahnini*,1 1School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK; 2Public Health Genetics Unit, Wort’s Causeway, Cambridge, UK Family-based analysis has revealed several loci for psoriasis and the locus, PSORS5, on chromosome 3q21 has been found in two independent studies. In this region, cystatin A (CSTA) encodes a skin barrier cystein protease inhibitor found in human sweat and it is over-expressed in psoriatic skin. Three CSTA markers at positions –190 (g.À190T4C), þ 162 (c.162T4C) and þ 344 (c.344C4T) were analysed in 107 unrelated patients and 216 matched controls. There was a significant trend for association with CSTA c.162T4C and psoriasis (odds ratio (OR) ¼ 3.45, Po0.001). Analysis of constructed haplotypes showed a highly significant association between disease and CSTA –190T/ þ 162C/ þ 344C (CSTA TCC) (P ¼ 10À6). In independent study, a TDT analysis in 126 nuclear families confirmed the over-transmission of CSTA TCC (P ¼ 0.0001). The presence of statistical interaction between CSTA TCC haplotype and HLA-Cw6 at PSORS1 locus was detected by performing TDT analysis on CSTA haplotypes stratified by the presence or absence of the risk allele at HLA-Cw6 locus.
    [Show full text]
  • Mutations in SERPINB7, Encoding a Member of the Serine Protease Inhibitor Superfamily, Cause Nagashima-Type Palmoplantar Keratosis
    REPORT Mutations in SERPINB7, Encoding a Member of the Serine Protease Inhibitor Superfamily, Cause Nagashima-type Palmoplantar Keratosis Akiharu Kubo,1,2,3,* Aiko Shiohama,1,4 Takashi Sasaki,1,2,3 Kazuhiko Nakabayashi,5 Hiroshi Kawasaki,1 Toru Atsugi,1,6 Showbu Sato,1 Atsushi Shimizu,7 Shuji Mikami,8 Hideaki Tanizaki,9 Masaki Uchiyama,10 Tatsuo Maeda,10 Taisuke Ito,11 Jun-ichi Sakabe,11 Toshio Heike,12 Torayuki Okuyama,13 Rika Kosaki,14 Kenjiro Kosaki,15 Jun Kudoh,16 Kenichiro Hata,5 Akihiro Umezawa,17 Yoshiki Tokura,11 Akira Ishiko,18 Hironori Niizeki,19 Kenji Kabashima,9 Yoshihiko Mitsuhashi,10 and Masayuki Amagai1,2,4 ‘‘Nagashima-type’’ palmoplantar keratosis (NPPK) is an autosomal recessive nonsyndromic diffuse palmoplantar keratosis characterized by well-demarcated diffuse hyperkeratosis with redness, expanding on to the dorsal surfaces of the palms and feet and the Achilles tendon area. Hyperkeratosis in NPPK is mild and nonprogressive, differentiating NPPK clinically from Mal de Meleda. We performed whole-exome and/or Sanger sequencing analyses of 13 unrelated NPPK individuals and identified biallelic putative loss-of-function mutations in SERPINB7, which encodes a cytoplasmic member of the serine protease inhibitor superfamily. We identified a major caus- ative mutation of c.796C>T (p.Arg266*) as a founder mutation in Japanese and Chinese populations. SERPINB7 was specifically present in the cytoplasm of the stratum granulosum and the stratum corneum (SC) of the epidermis. All of the identified mutants are predicted to cause premature termination upstream of the reactive site, which inhibits the proteases, suggesting a complete loss of the protease inhibitory activity of SERPINB7 in NPPK skin.
    [Show full text]
  • Structural Dynamics Investigation of Human Family 1 & 2 Cystatin
    RESEARCH ARTICLE Structural Dynamics Investigation of Human Family 1 & 2 Cystatin-Cathepsin L1 Interaction: A Comparison of Binding Modes Suman Kumar Nandy, Alpana Seal* Department of Biochemistry & Biophysics, University of Kalyani, Kalyani, West Bengal, India * [email protected] Abstract a11111 Cystatin superfamily is a large group of evolutionarily related proteins involved in numerous physiological activities through their inhibitory activity towards cysteine proteases. Despite sharing the same cystatin fold, and inhibiting cysteine proteases through the same tripartite edge involving highly conserved N-terminal region, L1 and L2 loop; cystatins differ widely in their inhibitory affinity towards C1 family of cysteine proteases and molecular details of these interactions are still elusive. In this study, inhibitory interactions of human family 1 & 2 cystatins with cathepsin L1 are predicted and their stability and viability are verified through OPEN ACCESS protein docking & comparative molecular dynamics. An overall stabilization effect is Citation: Nandy SK, Seal A (2016) Structural Dynamics Investigation of Human Family 1 & 2 observed in all cystatins on complex formation. Complexes are mostly dominated by van Cystatin-Cathepsin L1 Interaction: A Comparison of der Waals interaction but the relative participation of the conserved regions varied exten- Binding Modes. PLoS ONE 11(10): e0164970. sively. While van der Waals contacts prevail in L1 and L2 loop, N-terminal segment chiefly doi:10.1371/journal.pone.0164970 acts as electrostatic interaction site. In fact the comparative dynamics study points towards Editor: Claudio M Soares, Universidade Nova de the instrumental role of L1 loop in directing the total interaction profile of the complex either Lisboa Instituto de Tecnologia Quimica e Biologica, towards electrostatic or van der Waals contacts.
    [Show full text]
  • Cysteine Cathepsin Proteases: Regulators of Cancer Progression and Therapeutic Response
    REVIEWS Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response Oakley C. Olson1,2 and Johanna A. Joyce1,3,4 Abstract | Cysteine cathepsin protease activity is frequently dysregulated in the context of neoplastic transformation. Increased activity and aberrant localization of proteases within the tumour microenvironment have a potent role in driving cancer progression, proliferation, invasion and metastasis. Recent studies have also uncovered functions for cathepsins in the suppression of the response to therapeutic intervention in various malignancies. However, cathepsins can be either tumour promoting or tumour suppressive depending on the context, which emphasizes the importance of rigorous in vivo analyses to ascertain function. Here, we review the basic research and clinical findings that underlie the roles of cathepsins in cancer, and provide a roadmap for the rational integration of cathepsin-targeting agents into clinical treatment. Extracellular matrix Our contemporary understanding of cysteine cathepsin tissue homeostasis. In fact, aberrant cathepsin activity (ECM). The ECM represents the proteases originates with their canonical role as degrada- is not unique to cancer and contributes to many disease multitude of proteins and tive enzymes of the lysosome. This view has expanded states — for example, osteoporosis and arthritis4, neuro­ macromolecules secreted by considerably over decades of research, both through an degenerative diseases5, cardiovascular disease6, obe- cells into the extracellular
    [Show full text]
  • Anti-Cystatin a Antibody [1B12] (ARG57076)
    Product datasheet [email protected] ARG57076 Package: 50 μl anti-Cystatin A antibody [1B12] Store at: -20°C Summary Product Description Mouse Monoclonal antibody [1B12] recognizes Cystatin A Tested Reactivity Hu Tested Application WB Host Mouse Clonality Monoclonal Clone 1B12 Isotype IgG1, kappa Target Name Cystatin A Antigen Species Human Immunogen Recombinant fragment around aa. 1-98 of Human Cystatin A. Conjugation Un-conjugated Alternate Names STFA; Cystatin-A; AREI; STF1; Cystatin-AS; Stefin-A Application Instructions Application table Application Dilution WB Assay-dependent Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 11 kDa Properties Form Liquid Purification Purification with Protein A. Buffer PBS (pH 7.4), 0.02% Sodium azide and 10% Glycerol. Preservative 0.02% Sodium azide Stabilizer 10% Glycerol Concentration 1 mg/ml Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. www.arigobio.com 1/2 Bioinformation Database links GeneID: 1475 Human Swiss-port # P01040 Human Gene Symbol CSTA Gene Full Name cystatin A (stefin A) Background The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity.
    [Show full text]
  • Structural Basis for Unique Mechanisms of Folding and Hemoglobin Binding by a Malarial Protease
    Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease Stephanie X. Wang*, Kailash C. Pandey†, John R. Somoza‡, Puran S. Sijwali†, Tanja Kortemme§, Linda S. Brinen¶, Robert J. Fletterickʈ, Philip J. Rosenthal†, and James H. McKerrow*§** *Department of Pathology and the Sandler Center, Box 2550, Byers Hall N508, and †Department of Medicine, San Francisco General Hospital, Box 0811, University of California, San Francisco, CA 94143; §Department of Biopharmaceutical Sciences and California Institute for Quantitative Biomedical Research, and Departments of ¶Cellular and Molecular Pharmacology and ʈBiochemistry and Biophysics, University of California, San Francisco, CA 94143; and ‡Celera Genomics, 180 Kimball Way, South San Francisco, CA 94080 Edited by Robert M. Stroud, University of California, San Francisco, CA, and approved June 12, 2006 (received for review January 22, 2006) Falcipain-2 (FP2), the major cysteine protease of the human malaria analyses of FP2 and FP3 did not identify mechanistic or functional parasite Plasmodium falciparum, is a hemoglobinase and promis- roles for these sequence motifs because of uncertainties in their ing drug target. Here we report the crystal structure of FP2 in conformations (15, 16). X-ray-derived structural data would there- complex with a protease inhibitor, cystatin. The FP2 structure fore be key to elucidating the functions of the unique motifs and to reveals two previously undescribed cysteine protease structural guide rational drug design. motifs, designated FP2nose and FP2arm, in addition to details of the Here we report the structure of FP2 complexed with chicken egg active site that will help focus inhibitor design. Unlike most white cystatin.
    [Show full text]
  • 10Th Anniversary of the Human Genome Project
    Grand Celebration: 10th Anniversary of the Human Genome Project Volume 3 Edited by John Burn, James R. Lupski, Karen E. Nelson and Pabulo H. Rampelotto Printed Edition of the Special Issue Published in Genes www.mdpi.com/journal/genes John Burn, James R. Lupski, Karen E. Nelson and Pabulo H. Rampelotto (Eds.) Grand Celebration: 10th Anniversary of the Human Genome Project Volume 3 This book is a reprint of the special issue that appeared in the online open access journal Genes (ISSN 2073-4425) in 2014 (available at: http://www.mdpi.com/journal/genes/special_issues/Human_Genome). Guest Editors John Burn University of Newcastle UK James R. Lupski Baylor College of Medicine USA Karen E. Nelson J. Craig Venter Institute (JCVI) USA Pabulo H. Rampelotto Federal University of Rio Grande do Sul Brazil Editorial Office Publisher Assistant Editor MDPI AG Shu-Kun Lin Rongrong Leng Klybeckstrasse 64 Basel, Switzerland 1. Edition 2016 MDPI • Basel • Beijing • Wuhan ISBN 978-3-03842-123-8 complete edition (Hbk) ISBN 978-3-03842-169-6 complete edition (PDF) ISBN 978-3-03842-124-5 Volume 1 (Hbk) ISBN 978-3-03842-170-2 Volume 1 (PDF) ISBN 978-3-03842-125-2 Volume 2 (Hbk) ISBN 978-3-03842-171-9 Volume 2 (PDF) ISBN 978-3-03842-126-9 Volume 3 (Hbk) ISBN 978-3-03842-172-6 Volume 3 (PDF) © 2016 by the authors; licensee MDPI, Basel, Switzerland. All articles in this volume are Open Access distributed under the Creative Commons License (CC-BY), which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications.
    [Show full text]